JTL
LXEO icon

Jupiter Topco LLC’s Lexeo Therapeutics LXEO Stock Holding History

Jupiter Topco LLC’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.4M Buy
+3,954,691
New +$21.4M 0.01% 676

Other funds holding LXEO

AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Jupiter Topco LLC's LXEO Position: Q2 2026 in Review

Jupiter Topco LLC opened a new position in Lexeo Therapeutics (LXEO) in Q2 2026: 3,954,691 shares worth $18.4M. The stake represents 0.01% of the portfolio and ranks #676 among its holdings.

132 funds tracked by Wall St. Rank hold LXEO as of Q2 2026.

  • Jupiter Topco LLC held 3,954,691 shares of Lexeo Therapeutics worth $18.4M as of Q2 2026.
  • Lexeo Therapeutics was a new Jupiter Topco LLC position in Q2 2026.
  • Lexeo Therapeutics made up 0.01% of Jupiter Topco LLC's portfolio in Q2 2026, its #676 holding.
  • 132 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q2 2026.

Based on Jupiter Topco LLC's 13F filing for Q2 2026, filed 14 Aug 2026.